MedDataX Logo

Body Composition Measurements in Chronic Heart Failure

NCT02686866 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2016-02-22

No results posted yet for this study

Summary

Feeding optimization and nutritional assessment in patients with severe heart failure are challenging. The prevalence of cardiac cachexia may be underestimated by simple measurements of body weight and body mass index because many patients show relative reductions in muscle mass despite being of normal overall weight. Body composition measurement can be essential in chronic heart failure (CHF) patients to estimate sarcopenia. Chronic heart failure patients with cardiac cachexia have a mortality two to three times higher than noncachectic patients. Bedside body composition measurements can reveal developing cardiac cachexia hence can be useful in prevention.

Conditions

  • Cachexia
  • Sarcopenia
  • Body Composition

Interventions

DEVICE

bioelectrical impedance analysis (Bodystat, Quadscan 4000)

DEVICE

dual-energy X-ray absorptiometry (Hologic, Delphi QDR)

DEVICE

hand grip strength

Sponsors & Collaborators

  • Hungarian Institute of Cardiology

    lead OTHER_GOV

Principal Investigators

  • Peter Andreka, MD, PhD · Hungarian Institute of Cardiology

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Hungary

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02686866 on ClinicalTrials.gov